Overview
Short stature-delayed bone age due to thyroid hormone metabolism deficiency is a rare endocrine disorder caused by defects in the intracellular metabolism of thyroid hormones, leading to a form of congenital hypothyroidism. This condition is primarily associated with mutations in the SBP2 (SECISBP2) gene, which encodes a selenocysteine insertion sequence-binding protein essential for the synthesis of selenoproteins, including the deiodinase enzymes responsible for converting the prohormone thyroxine (T4) into the biologically active triiodothyronine (T3). Impaired deiodinase activity results in abnormal thyroid hormone levels, typically characterized by elevated T4 and reverse T3 (rT3) with low T3 levels, and mildly elevated TSH. The condition primarily affects the skeletal and endocrine systems. Key clinical features include proportionate short stature, significantly delayed bone age, and growth retardation during childhood. Patients may also exhibit features of mild hypothyroidism at the tissue level despite apparently normal or elevated circulating T4 levels, which can make initial diagnosis challenging. Additional features may include transient hearing impairment, mild intellectual delay, and increased sensitivity to oxidative stress due to broader selenoprotein deficiency. The thyroid hormone profile is distinctive and helps guide diagnosis. Treatment options are limited and primarily supportive. Selenium supplementation and careful thyroid hormone replacement with T3 (liothyronine) have been explored in some patients, with variable clinical benefit. Growth hormone therapy is generally not indicated unless concurrent growth hormone deficiency is documented. Long-term monitoring of growth, bone maturation, thyroid function, and neurodevelopmental outcomes is recommended. The condition is extremely rare, with only a small number of families reported worldwide.
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Short stature-delayed bone age due to thyroid hormone metabolism deficiency.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Short stature-delayed bone age due to thyroid hormone metabolism deficiency at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Short stature-delayed bone age due to thyroid hormone metabolism deficiency.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Short stature-delayed bone age due to thyroid hormone metabolism deficiency.
Community
No community posts yet. Be the first to share your experience with Short stature-delayed bone age due to thyroid hormone metabolism deficiency.
Start the conversation →Latest news about Short stature-delayed bone age due to thyroid hormone metabolism deficiency
No recent news articles for Short stature-delayed bone age due to thyroid hormone metabolism deficiency.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Short stature-delayed bone age due to thyroid hormone metabolism deficiency
What is Short stature-delayed bone age due to thyroid hormone metabolism deficiency?
Short stature-delayed bone age due to thyroid hormone metabolism deficiency is a rare endocrine disorder caused by defects in the intracellular metabolism of thyroid hormones, leading to a form of congenital hypothyroidism. This condition is primarily associated with mutations in the SBP2 (SECISBP2) gene, which encodes a selenocysteine insertion sequence-binding protein essential for the synthesis of selenoproteins, including the deiodinase enzymes responsible for converting the prohormone thyroxine (T4) into the biologically active triiodothyronine (T3). Impaired deiodinase activity results i
How is Short stature-delayed bone age due to thyroid hormone metabolism deficiency inherited?
Short stature-delayed bone age due to thyroid hormone metabolism deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Short stature-delayed bone age due to thyroid hormone metabolism deficiency typically begin?
Typical onset of Short stature-delayed bone age due to thyroid hormone metabolism deficiency is childhood. Age of onset can vary across affected individuals.